TOTAL ASSETS $43,724,000 $36,677,000
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and accrued expenses $4,279,000 $2,913,000
Income taxes payable 592,000 535,000
Line of credit 1,599,000 1,256,000
Current maturities of long-term debt 264,000 548,000
Total current liabilities 6,734,000 5,252,000
Other liabilities
Long-term debt, net of current portion 4,570,000 3,509,000
Total liabilities 11,304,000 8,761,000
Stockholders' Equity:
Preferred stock, $.001 par value
(1,500,000 authorized, no shares
issued and outstanding) - -
Common stock; par value $.001 per
share; 20,000,000 shares authorized;
13,709,098 and 13,631,898 shares issued
and outstanding 14,000 14,000
Additional paid-in capital 26,953,000 26,629,000
Accumulated other comprehensive income 321,000 334,000
Retained earnings 9,818,000 5,981,000
37,106,000 32,958,000
Less: cost of 270,534 and 249,184
shares of common stock in treasury (1,971,000) (1,686,000)
Less: Unearned compensation (2,715,000) (3,356,000)
Total stockholders' equity 32,420,000 27,916,000
TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY $43,724,000 $36,677,000
MEDIFAST, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT
'/>"/>
| SOURCE Medifast, Inc. Copyright©2008 PR Newswire. All rights reserved |